blinatumomab
amgen,astellas
['blinatumomab']
congress | #ash22 | poster
sabina chiaretti presented results from the gimema lal2317 study, which aimed to refine risk relapse categories of ph-like #all, based on genomic features. pts with ph-like all often relapse after blinatumomab treatment.
#allsm #medicalcongress 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm